Home › Funds › RA CAPITAL MANAGEMENT, L.P. › ZLAB
RA CAPITAL MANAGEMENT, L.P. position in ZLAB
Zai Lab Ltd · Health Care
RA CAPITAL MANAGEMENT, L.P. reported holding 5,743,533 shares of ZLAB (Zai Lab Ltd) in its Q2 2026 13F filing — a position valued at US$109.1M, representing 0.95% of its reported portfolio and ranking #26 among its reported holdings. RA CAPITAL MANAGEMENT, L.P. has disclosed ZLAB holdings in 4 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How RA CAPITAL MANAGEMENT, L.P.'s ZLAB position evolved
RA CAPITAL MANAGEMENT, L.P. first disclosed a stake in ZLAB in Q4 2024 at 1,295,040 shares (US$33.9M). The position peaked in Q2 2026 at 5,743,533 shares, worth US$109.1M. Across 4 filings, RA CAPITAL MANAGEMENT, L.P. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 5,743,533 shares valued at US$109.1M — an increase of 36,271 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 1.30M | $33.92M | New |
| Q1 2025 | 1.30M | $46.80M | Hold |
| Q1 2026 | 5.71M | $107.35M | New |
| Q2 2026 | 5.74M | $109.13M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZLAB and 13F data
ZLAB (Zai Lab Ltd) is a Health Care company. 14 other funds we track also report a position in ZLAB — the largest reported positions include RTW INVESTMENTS, LP (US$124.9M), TCG Crossover Management, LLC (US$116.6M), ADAR1 Capital Management, LLC (US$64.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZLAB
- RTW INVESTMENTS, LP 6.57M sh · $124.91M · Q2 2026
- TCG Crossover Management, LLC 6.14M sh · $116.61M · Q2 2026
- ADAR1 Capital Management, LLC 3.37M sh · $64.01M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.90M sh · $36.14M · Q2 2026
- Rock Springs Capital Management LP 814.71K sh · $15.48M · Q2 2026
- B Group, Inc. 450.65K sh · $8.56M · Q2 2026
More on RA CAPITAL MANAGEMENT, L.P.
FAQ
How long has RA CAPITAL MANAGEMENT, L.P. held ZLAB?
RA CAPITAL MANAGEMENT, L.P. has disclosed ZLAB holdings in 4 of the last 7 reported quarters, going back to Q4 2024.
What is RA CAPITAL MANAGEMENT, L.P.'s current position in ZLAB?
As of Q2 2026, RA CAPITAL MANAGEMENT, L.P. holds 5.74M shares of ZLAB (Zai Lab Ltd), valued at $109.13M, representing 0.95% of its reported portfolio and ranking #26.
Has RA CAPITAL MANAGEMENT, L.P. been buying or selling ZLAB?
In the latest 13F filing (Q2 2026), RA CAPITAL MANAGEMENT, L.P. increased its position in ZLAB. The position peaked in Q2 2026 at 5.74M shares.
Which other funds hold ZLAB?
Other major institutional holders of ZLAB include RTW INVESTMENTS, LP, TCG Crossover Management, LLC, ADAR1 Capital Management, LLC, among 14 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.